IL162645A0 - solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds - Google Patents

solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds

Info

Publication number
IL162645A0
IL162645A0 IL16264503A IL16264503A IL162645A0 IL 162645 A0 IL162645 A0 IL 162645A0 IL 16264503 A IL16264503 A IL 16264503A IL 16264503 A IL16264503 A IL 16264503A IL 162645 A0 IL162645 A0 IL 162645A0
Authority
IL
Israel
Prior art keywords
compounds
pharmaceuticals
benzazepine
solid salts
use inthe
Prior art date
Application number
IL16264503A
Other languages
English (en)
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of IL162645A0 publication Critical patent/IL162645A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL16264503A 2002-01-16 2003-01-15 solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds IL162645A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075621 2002-01-16
NL1019762 2002-01-17
PCT/EP2003/000515 WO2003059939A1 (en) 2002-01-16 2003-01-15 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds

Publications (1)

Publication Number Publication Date
IL162645A0 true IL162645A0 (en) 2005-11-20

Family

ID=26077601

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16264503A IL162645A0 (en) 2002-01-16 2003-01-15 solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds

Country Status (15)

Country Link
US (1) US6998398B2 (enExample)
EP (1) EP1468010A1 (enExample)
JP (1) JP4384495B2 (enExample)
KR (1) KR100979077B1 (enExample)
CN (1) CN100591689C (enExample)
AU (1) AU2003206755B2 (enExample)
BR (1) BR0306701A (enExample)
CA (1) CA2473447A1 (enExample)
HR (1) HRP20040560A2 (enExample)
IL (1) IL162645A0 (enExample)
MX (1) MXPA04006887A (enExample)
NO (1) NO330528B1 (enExample)
PL (1) PL371511A1 (enExample)
RU (1) RU2303041C2 (enExample)
WO (1) WO2003059939A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050009031A (ko) * 2003-07-15 2005-01-24 엘지전자 주식회사 1회 기록 가능한 광디스크 및 광디스크의 관리정보 기록방법
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
AR046454A1 (es) * 2003-11-18 2005-12-07 Solvay Pharm Gmbh Uso de un compuesto de acido benzazepin-n-acetico, composicion farmaceutica, y procedimiento para la produccion de dicha composicion farmaceutica
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
MX2007006279A (es) 2004-12-15 2007-06-14 Solvay Pharm Gmbh Composiciones farmaceuticas que comprenden inhibidores de nep, inhibidores del sistema de produccion de endotelina endogena, e inhibidores de hmg coa-reductasa.
US20060159748A1 (en) * 2004-12-23 2006-07-20 Rajesh Jain Oral immediate release formulation of a poorly water-soluble active substance
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders
HU227696B1 (en) * 2006-04-13 2011-12-28 Egyt Gyogyszervegyeszeti Gyar Zinc salt of rosuvastatin, process for its preparation and pharmaceutical compositions containing it
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu
PL424453A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
DE19750002A1 (de) * 1997-11-12 1999-05-20 Solvay Pharm Gmbh Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen

Also Published As

Publication number Publication date
KR100979077B1 (ko) 2010-08-31
EP1468010A1 (en) 2004-10-20
US20050038012A1 (en) 2005-02-17
KR20040089106A (ko) 2004-10-20
CN1617883A (zh) 2005-05-18
AU2003206755B2 (en) 2008-07-17
NO330528B1 (no) 2011-05-09
JP4384495B2 (ja) 2009-12-16
RU2303041C2 (ru) 2007-07-20
US6998398B2 (en) 2006-02-14
CN100591689C (zh) 2010-02-24
HRP20040560A2 (en) 2004-10-31
BR0306701A (pt) 2004-12-28
JP2005520809A (ja) 2005-07-14
RU2004124840A (ru) 2006-01-20
CA2473447A1 (en) 2003-07-24
MXPA04006887A (es) 2004-12-06
PL371511A1 (en) 2005-06-27
NO20043295L (no) 2004-08-06
WO2003059939A1 (en) 2003-07-24
HK1072946A1 (zh) 2005-09-16
AU2003206755A1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
HUP0402236A3 (en) Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
SI1390023T1 (sl) Farmacevtske soli spojin 1-fenil-3-dimetilamino-propana
IL163990A0 (en) Pharmaceutical preparation containing oxycodone and naloxone
IL187528A0 (en) Use of pyrimidine compounds in the manufacture of medicaments
IL173639A0 (en) Ppar-activating compound and pharmaceutical composition containing same
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
PL359321A1 (en) New salt perindopryl and pharmaceutical composunds containing it
TWI339662B (en) Arylvinylazacycloalkane compounds and methods of preparation and use thereof
IL162645A0 (en) solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds
GB0202900D0 (en) Novel formulations of drugs
GB0207410D0 (en) Compounds and their therapeutic use
PL367639A1 (en) Novel heterocyclic compound and medicinal use thereof
AU7402201A (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2003298725A8 (en) Preparation of metallotexaphyrins
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
GB0312844D0 (en) Use of compounds in medicine
AU2003288318A8 (en) Pharmaceutical compounds specifically inhibiting smooth muscle pde5, pharmaceutical compositions containing same and therapeutic uses thereof
IL165356A0 (en) Preparation of 4-haloalkylkylnicotinamides
GB0225702D0 (en) Oral formulation of moisutre-sensitive drugs
AU2003268724B2 (en) Isoquinoline compounds and medicinal use thereof
SI1699764T1 (sl) Soli bis-dikarboksilne kisline benazeprila in priprava benazeprila preko teh soli
GB0208324D0 (en) Administration of beneficial substances
SI1289514T1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
GB0221955D0 (en) Compounds and their medical uses

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees